Elevated levels of C-reactive protein (CRP) have been linked to an increased risk of cardiovascular events in ACS patients [3]. Serum uric acid, a mediator of inflammation, can increase the risk of atherosclerosis by causing endothelial dysfunction and inflammation in the vasculature [4]. This evidence concerns the gene CRP and atherosclerosis.